A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
Clinical trial NCT04958239 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04958239
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2026-04-27
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.